These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 34481722)

  • 21. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022.
    Shah MM; Patel K; Milucky J; Taylor CA; Reingold A; Armistead I; Meek J; Anderson EJ; Weigel A; Reeg L; Como-Sabetti K; Ropp SL; Muse A; Bushey S; Shiltz E; Sutton M; Talbot HK; Chatelain R; Havers FP;
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13107. PubMed ID: 36875205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
    Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
    J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial and fungal co-infections among COVID-19 patients in intensive care unit.
    Yang S; Hua M; Liu X; Du C; Pu L; Xiang P; Wang L; Liu J
    Microbes Infect; 2021; 23(4-5):104806. PubMed ID: 33684520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-infection with respiratory pathogens among COVID-2019 cases.
    Zhu X; Ge Y; Wu T; Zhao K; Chen Y; Wu B; Zhu F; Zhu B; Cui L
    Virus Res; 2020 Aug; 285():198005. PubMed ID: 32408156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timeliness and completeness of laboratory-based surveillance of COVID-19 cases in England.
    Clare T; Twohig KA; O'Connell AM; Dabrera G
    Public Health; 2021 May; 194():163-166. PubMed ID: 33945929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased antimicrobial resistance during the COVID-19 pandemic.
    Lai CC; Chen SY; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
    Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study.
    Chen S; Zhu Q; Xiao Y; Wu C; Jiang Z; Liu L; Qu J
    Clin Respir J; 2021 Jul; 15(7):815-825. PubMed ID: 33818909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case-control study.
    Nasir N; Rehman F; Omair SF
    J Med Virol; 2021 Jul; 93(7):4564-4569. PubMed ID: 33822390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.
    Rodriguez-Nava G; Yanez-Bello MA; Trelles-Garcia DP; Chung CW; Egoryan G; Friedman HJ
    Med Sci Monit; 2020 Nov; 26():e928754. PubMed ID: 33188161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
    Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M
    Infection; 2021 Jun; 49(3):559-562. PubMed ID: 33393065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical bacterial co-infections among patients with COVID-19: A study from India.
    Chaudhry R; Sreenath K; Batra P; Vinayaraj EV; Rathor N; Saikiran K; Aravindan A; Singh V; Brijwal M; Soneja M; Verma N; Subramanium R; Singh UB; Guleria R
    J Med Virol; 2022 Jan; 94(1):303-309. PubMed ID: 34491594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
    Li J; Wang J; Yang Y; Cai P; Cao J; Cai X; Zhang Y
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):153. PubMed ID: 32962731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic linkage of COVID-19 test results between Public Health England's Second Generation Surveillance System and UK Biobank.
    Armstrong J; Rudkin JK; Allen N; Crook DW; Wilson DJ; Wyllie DH; O'Connell AM
    Microb Genom; 2020 Jul; 6(7):. PubMed ID: 32553051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
    Liu HH; Yaron D; Piraino AS; Kapelusznik L
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients.
    Bolker A; Coe K; Smith J; Stevenson K; Wang SH; Reed E
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115558. PubMed ID: 34731685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
    Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
    Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study.
    Bhatt PJ; Shiau S; Brunetti L; Xie Y; Solanki K; Khalid S; Mohayya S; Au PH; Pham C; Uprety P; Nahass R; Narayanan N
    Clin Infect Dis; 2021 Jun; 72(12):e995-e1003. PubMed ID: 33216875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
    Byrd KM; Beckwith CG; Garland JM; Johnson JE; Aung S; Cu-Uvin S; Farmakiotis D; Flanigan T; Gillani FS; Macias-Gil R; Mileno M; Ramratnam B; Rybak NR; Sanchez M; Tashima K; Mylonakis E; Kantor R
    J Int AIDS Soc; 2020 Jul; 23(7):e25573. PubMed ID: 32657527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.